---
figid: PMC9578081__EJE-22-0320fig5
figtitle: 11-Oxygenated C19 steroids are the predominant androgens responsible for
  hyperandrogenemia in Cushing’s disease
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9578081
filename: EJE-22-0320fig5.jpg
figlink: /pmc/articles/PMC9578081/figure/fig5/
number: F5
caption: Adrenal steroidogenesis and the effect of the two steroidogenesis inhibitors
  metyrapone and osilodrostat. (A) Pathway of adrenal steroidogenesis including 11oxC19
  androgen synthesis. (B) Effect of the steroidogenesis inhibitors metyrapone and
  osilodrostat on adrenal steroidogenesis including inhibition of CYP11B1, CYP11B2
  and also the cholesterol side chain cleavage complex, 17α-hydroxylase and 21-hydroxylase.
papertitle: 11-Oxygenated C19 steroids are the predominant androgens responsible for
  hyperandrogenemia in Cushing’s disease.
reftext: Hanna F Nowotny, et al. Eur J Endocrinol. 2022 Nov 1;187(5):663-673.
year: '2022'
doi: 10.1530/EJE-22-0320
journal_title: European Journal of Endocrinology
journal_nlm_ta: Eur J Endocrinol
publisher_name: Bioscientifica Ltd
keywords: ''
automl_pathway: 0.8441497
figid_alias: PMC9578081__F5
figtype: Figure
redirect_from: /figures/PMC9578081__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9578081__EJE-22-0320fig5.html
  '@type': Dataset
  description: Adrenal steroidogenesis and the effect of the two steroidogenesis inhibitors
    metyrapone and osilodrostat. (A) Pathway of adrenal steroidogenesis including
    11oxC19 androgen synthesis. (B) Effect of the steroidogenesis inhibitors metyrapone
    and osilodrostat on adrenal steroidogenesis including inhibition of CYP11B1, CYP11B2
    and also the cholesterol side chain cleavage complex, 17α-hydroxylase and 21-hydroxylase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAR
  - GUCY2C
  - CD163L1
  - CYP11A1
  - CYP17A1
  - HSD3B2
  - SULT2A1
  - CYB5A
  - AKR1C3
  - SRD5A1
  - CYP21A2
  - HSD11B2
  - CYP11B2
  - POMC
  - CRH
---
